Sort by
Keyphrases
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Targeted Delivery
100%
Fusion Protein
100%
Human Endostatin
100%
Enhanced Antitumor Efficacy
100%
Antibody mutants
100%
Endostatin
87%
IgG3
62%
Anti-HER2 Antibody
62%
Anti-HER2
50%
EMT6
37%
Antitumor Activity
25%
Antibody Protein
25%
Phase II Trial
12%
Tumor
12%
Tumor Targeting
12%
Humanized
12%
Antitumor Efficacy
12%
Antiangiogenic
12%
Improved Survival
12%
Endothelial Cell Proliferation
12%
Human Breast Tumor
12%
Breast Cancer Xenograft
12%
Basic Fibroblast Growth Factor (bFGF)
12%
Tube Formation
12%
Prolonged Half-life
12%
Enhanced Antitumor Activity
12%
SKBR3
12%
Induced Endothelial Cells
12%
Antibody Specificity
12%
3' End
12%
Tumor Inhibition
12%
Murine Mammary Tumors
12%
Breast Tumor Model
12%
Medicine and Dentistry
Chimeric Protein
100%
Endostatin
100%
Immunoglobulin G3
33%
Antineoplastic Activity
25%
Breast Tumor
16%
Epidermal Growth Factor Receptor 2
16%
In Vitro
8%
Breast Cancer
8%
Neoplasm
8%
Tumor Progression
8%
Tumor Model
8%
Vasculotropin
8%
Endothelial Cell
8%
Cell Proliferation
8%
Tumor Xenograft
8%
Antiangiogenic
8%
Antibody Specificity
8%
Tumor
8%
Immunoglobulin G3 Antibody
8%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Protein
100%
Endostatin
100%
Immunoglobulin G3
33%
Antitumor Activity
25%
Breast Tumor
16%
Epidermal Growth Factor Receptor 2
16%
Antiangiogenic
8%
Tumor Model
8%
Breast Cancer
8%
Tumor Growth
8%
Vasculotropin
8%
Immunoglobulin G3 Antibody
8%
Neoplasm
8%
Immunology and Microbiology
Endostatin
100%
Immunoglobulin G3
33%
Antineoplastic Activity
25%
Wild Type
25%
Xenograft
8%
Cell Proliferation
8%
Antibody Specificity
8%
Vasculotropin
8%
Immunoglobulin G3 Antibody
8%
In Vitro
8%